Baytril Max 100 mg/ml Solution for Injection for Cattle and Pigs

phase), because it could select antimicrobial-resistant bacteria within the intestinal
microbiota of the calf and increase the faecal shedding of these bacteria.
Fluoroquinolones should be reserved for the treatment of clinical conditions
which have responded poorly, or are expected to respond poorly, to other
classes of antimicrobials.
Use of the veterinary medicinal product deviating from the instructions given in
this SPC may increase the prevalence of bacteria resistant to the
fluoroquinolones and may decrease the effectiveness of treatment with other
quinolones due to the potential for cross resistance.

Amended pages: January 2026
Enrofloxacin is eliminated renally. As with all fluoroquinolones, delayed
excretion can therefore be expected in the presence of existing renal damage.
Not for use for prophylaxis.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Direct contact with the skin should be avoided due to sensitisation, contact dermatitis
and possible hypersensitivity reactions.
People with known hypersensitivity to (fluoro)quinolones should avoid contact
with the veterinary medicinal product. Wash hands after use.
In the event of accidental splash into the eye, rinse with large amounts of clean
water. If irritation occurs, seek medical advice.
Do not eat, drink or smoke while handling the veterinary medicinal product.
Take care to avoid accidental self-injection.
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or label to the physician.
Special precautions for the protection of the environment:
Not applicable.
3.6 Adverse events
Cattle and pigs:
Rare
(1 to 10 animals / 10,000
animals treated):
Injection site reddening
, Injection site swelling
Circulatory shock
Very rare
(<1 animal / 10,000 animals
treated, including isolated
reports):
Digestive tract disorders
1
Transitory,regress within a few days without further therapeutic measures.
With intravenous treatment in cattle.
In calves.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

Amended pages: January 2026
7.5 ml of the veterinary medicinal product per 100 kg BW and day5 ml of the veterinary medicinal product per 100 kg BW and day0.75 ml of the veterinary medicinal product per 10 kg BW and day
3.7 Use during pregnancy, lactation or lay
Pregnancy and lactation:
Can be used during pregnancy and lactation.
3.8 Interaction with other medicinal products and other forms of interaction
Antagonist effects due to concurrent administration of macrolides and
tetracyclines may occur. Enrofloxacin may interfere with the metabolism of
theophylline, decreasing theophylline clearance resulting in increased plasma
levels of theophylline.
3.9 Administration routes and dosage
Cattle:
Subcutaneous use (respiratory disease) or Intravenous use (
The dosage for respiratory disease is 7.5 mg enrofloxacin per kg body weight
(BW) for a single treatment by subcutaneous administration (s.c.
This is equivalent to:
Do not administer more than 15 ml (cattle) or 7.5 ml (calf) per injection site (
In case of serious or chronic respiratory disease a second injection may be required
after 48 hours.
The dosage for the treatment of mastitis is 5 mg enrofloxacin per kg body
weight (BW) by intravenous administration (i.v.).
This is equivalent to
The treatment of mastitis should be exclusively by intravenous application
on 2 to 3 consecutive days.
Pigs:
Intramuscular use.
The dosage for respiratory tract infections is 7.5 mg enrofloxacin per kg body
weight for a single treatment by intramuscular administration (i.m.) into the neck
muscles behind the ear.
This is equivalent to:
Do not administer more than 7.5 ml per injection site (i.m.). In cases of serious
or chronic respiratory disease a second injection may be required after 48 hours.

Amended pages: January 2026
Repeated injections should be made at different injection sites.
To ensure a correct dosage, body weight should be determined as accurately as
possible.
The stopper may be safely punctured up to 20 times.
3.10 Symptoms of overdose (and where applicable, emergency procedures and
antidotes)
In cattle a dose of 25 mg/kg bodyweight administered by the subcutaneous route
for 15 consecutive days is tolerated without any clinical symptoms. Higher doses
in cattle and doses of around 25 mg/kg and above in pigs may cause lethargy,
lameness, ataxia, slight salivation and muscle tremors.
Do not exceed the recommended dose. In accidental overdose there is no antidote
and treatment should be symptomatic.
3.11 Special restrictions for use and special conditions for use, including
restrictions on the use of antimicrobial and antiparasitic veterinary
medicinal products in order to limit the risk of development of resistance
Not applicable.
3.12 Withdrawal periods
Cattle:
Meat and offal:
s.c.: 14 days
i.v.: 7 days

Milk:
s.c.: 120 hours
i.v.: 72 hours
Pigs:
Meat and offal: i.m